Biorex Healthcare Pvt

Company snapshot

Biorex is driven by the passion of purpose, partnerships and teamwork to transform unaffordable therapies into cost effective regimes for the common man. We at Biorex are constantly on the move to procure/outsource products of the highest quality by ensuring that our brands are manufactured at GMP/WHO-GMP approved facilities without putting a burden on the consumer. The lifecycle of a human body i

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Biorex Healthcare Pvt. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Biorex Healthcare Pvt.

1. Jun 8, 2026 Clinical update

   NEPA-22-01 — Phase 3

View all clinical trial activity →

• What is Biorex Healthcare Pvt?

  Helsinn Birex Pharmaceuticals is a pharma organization headquartered in Dublin, IE. Primary therapeutic focus areas include Chemotherapy-induced nausea and vomiting. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public F

• Is Biorex Healthcare Pvt publicly traded?

  Biorex Healthcare Pvt appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Biorex Healthcare Pvt develop or market?

  We link 14 drug profile(s) where Biorex Healthcare Pvt is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/helsinn-birex-pharmaceuticals-ltd#company-drugs.

• What are the latest developments for Biorex Healthcare Pvt?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Biorex Healthcare Pvt focus on?

  Biorex Healthcare Pvt focuses on Chemotherapy-induced nausea and vomiting based on our analysis of their pipeline programs and drug development activities.